Tyrosine kinase inhibitors therapy for hepatocellular carcinoma in patients waiting for liver transplant: is it safe?

被引：0
|
作者：
Conte, G. [1 ]
Mocchegiani, F. [2 ]
Cacciaguerra, A. Benedetti [2 ]
Rossi, R. [3 ]
Vecchi, A. [1 ]
Gaudenzi, F. [2 ]
Roccheggiani, M. [2 ]
Borrelli, G. [2 ]
Quercetti, D. [2 ]
Dalla Bona, E. [1 ]
Nicolini, D. [1 ]
Vivarelli, M. [2 ]
机构：
[1] Osped Riuniti Ancona, Clin Chirurg Epatobiliare Pancreat & Trapianti, Ancona, Italy
[2] Univ Politecn Marche, Ancona, Italy
[3] Ospedali Riuniti Ancona, Clin Chirurg Epatobiliare Pancreat Trapianti, Ancona, Italy
来源：
TRANSPLANTATION | 2023年 / 107卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
eP-460
引用
收藏
页码：273 / 273
页数：1
相关论文
共 50 条
  • [21] TRANSARTERIAL CHEMOEMBOLIZATION UTILITY AS A BRIDGE TO LIVER TRANSPLANT FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA DURING THE WAITING LIST
    Perez-Saborido, Baltasar
    Barra-Valencia, Vanessa
    Donat-Garrido, Maria
    Gimeno-Calvo, Alberto
    Jimenez de los Galanes-Marchan, Santos
    Fundora-Suarez, Yillian
    Lopez-Jara, Vanesa
    Carlos Meneu-Diaz, Juan
    Adradelo de Usera, Manuel
    Moreno-Gonzalez, Enrique
    TRANSPLANT INTERNATIONAL, 2009, 22 : 212 - 213
  • [22] ASSIGNING MELD SCORE FOR HEPATOCELLULAR CARCINOMA FOR PATIENTS ON WAITING LIST IN A SINGAPORE LIVER TRANSPLANT CENTRE
    Chang, Stephen K. Y.
    Bhasin, Rakesh
    Da Costa, Maureen
    Shridhar, Iyer
    Lee, Victor
    Madhavan, Krishnakumar
    LIVER TRANSPLANTATION, 2008, 14 (07) : S125 - S125
  • [23] Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates
    Castroagudín, JF
    Delgado, M
    Villanueva, A
    Bustamante, M
    Martínez, J
    Otero, E
    Tomé, S
    Martínez, SM
    Segade, FR
    Conde, R
    Dominguez-Muñoz, E
    Varo, E
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3871 - 3873
  • [24] Maintenance Therapy With Tyrosine Kinase Inhibitors After Transplant in Patients With Chronic Myeloid Leukemia
    Bar, Merav
    Radich, Jerald
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (03): : 308 - 315
  • [25] DAAs Therapy Before Liver Transplant In Patients With Hepatocellular Carcinoma And HCV Liver Disease
    Pascual, Sonia
    Irurzun, Javier
    Rodriguez, Maria
    Rodriguez, Gonzalo
    Bellot, Pablo
    Carnicer, Fernando
    Melgar, Paola
    Bernabe, Juan M.
    Alcazar, Candido
    Franco, Mariano
    Palazon, Jose Maria
    Lluis, Felix
    HEPATOLOGY, 2017, 66 : 876A - 876A
  • [26] Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma
    Zhuang, Y.
    Chen, Y.
    Du, S.
    Hu, Y.
    Zeng, Z. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E360 - E360
  • [27] LIVER TRANSPLANT ALLOCATION TO PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Dawwas, Muhammad F.
    Watson, Christopher J.
    Gimson, Alexander E.
    HEPATOLOGY, 2008, 48 (04) : 351A - 351A
  • [28] Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma
    Tian, Yichen
    Lei, Yongrong
    Fu, Yuna
    Sun, Heng
    Wang, Jianhua
    Xia, Feng
    CURRENT CANCER DRUG TARGETS, 2022, 22 (06) : 454 - 462
  • [29] Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma
    Rimassa, Lorenza
    Danesi, Romano
    Pressiani, Tiziana
    Merle, Philippe
    CANCER TREATMENT REVIEWS, 2019, 77 : 20 - 28
  • [30] RISKS OF VARICEAL BLEEDING IN PATIENTS WITH HEPATOCELLULAR CARCINOMA RECEIVING IMMUNE CHECKPOINT INHIBITORS AND/OR TYROSINE KINASE INHIBITORS (TIKS)
    Liang, Jing
    Zhang, Xu
    Ha, Fushuang
    HEPATOLOGY, 2024, 80
12345